Navigation Links
New test shows promise for accurate early diagnosis of Turner syndrome
Date:12/8/2010

Chevy Chase, MDA recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM) has demonstrated a novel and accurate test for early diagnosis of Turner syndrome. Turner syndrome affects one in 1,500 to 2,000 female live births and early diagnosis allows for the timely management of short stature and co-morbid conditions including cardiac and renal problems.

Turner syndrome (TS) is the most common genetic problem affecting girls with short stature. Average adult height in untreated girls with TS is 4 feet, 8 inches, yet with early diagnosis and initiation of growth hormone therapy, normal or near-normal adult stature can be achieved. Unfortunately, the vast majority of girls with TS go unrecognized until after 10 years of age. This new study suggests a new way to diagnose TS to help prevent delayed recognition.

"We have developed a novel approach for diagnosing TS that can be used to practically test large numbers of girls and is much quicker and less expensive than the current methods," said Scott Rivkees, MD, of Yale University School of Medicine in New Haven, Conn. and lead author of the study. "The new test would also provide the benefit of early detection of other health conditions associated with TS, such as potential renal and cardiac problems."

TS occurs when an X-chromosome is completely or partially deleted. In this study, researchers developed a test based on a quantitative method of genotyping to detect X-chromosome abnormalities. Of 90 clinically-confirmed TS individuals tested, the assay correctly identified 87 (96.7 percent).

"Because of the small amount of DNA needed for the test, ample DNA can be extracted from cheek swabs or from newborn screening blood spots that are routinely collected," said Rivkees. "If broadly used in the clinical setting at young ages, this test can prevent the delayed recognition of TS."


'/>"/>

Contact: Aaron Lohr
alohr@endo-society.org
240-482-1380
The Endocrine Society
Source:Eurekalert

Page: 1

Related medicine news :

1. Worm Therapy Shows Promise for Ulcerative Colitis
2. Celebrex Shows Potential in Preventing Some Skin Cancers: Study
3. New prostate cancer imaging shows real-time tumor metabolism
4. PARP inhibitor, MK-4827, shows anti-tumor activity in first trial in humans
5. Wake up, Mom -- study shows gender differences in sleep interruptions
6. Depression linked to HIV risk among South African young people, study shows
7. Gene Therapy Shows Potential Against Heart Failure
8. New treatment for lung cancer shows promise
9. Adding pharmacists to docs offices helps patient outcomes, study shows
10. Hurdles ahead for health care reform primary care model, U-M study shows
11. Pleasurable behaviors reduce stress via brain pathways, research shows
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased to announce the ... July 17, 2017, Ms. Vu will join West Dermatology’s large network of medical and ... skin cancer , and more. She graduated from the University of Florida College ...
(Date:7/21/2017)... ... July 21, 2017 , ... ... (ACL) offer patients improved quality of life five years after injury, according to ... Annual Meeting in Toronto, Ontario, Canada. The study followed patients for five years ...
(Date:7/20/2017)... Viejo, CA (PRWEB) , ... July 20, 2017 , ... ... when placed between two clips in the FCPX timeline. This effect isolates horizontal and ... transition in this package contains either a rotating or flipping animation and can be ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) ... progresses rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a ... relapse. With such a challenging diagnosis that requires immediate action, patients and ...
(Date:7/20/2017)... (PRWEB) , ... July 20, 2017 , ... ... law firm headquartered in Houston, is pleased to announce their expansion to the ... affordable housing experience, directors Alysse Hollis and Ronald Bell, and of counsels, John ...
Breaking Medicine News(10 mins):
(Date:6/30/2017)... , June 30, 2017 In vitro ... the start of May, at least ten diagnostic companies ... private investments, public offerings and a loan facility.  The ... to almost $80 million.  Kalorama Information provides a monthly ... its Diagnostics Knowledge Center. ...
(Date:6/30/2017)... HIGH POINT, N.C. , June 29, 2017  Axium Pharmaceuticals ... innovations for developing improved novel formulations and alternative dosage forms ... ... transmucosal delivery is based on our waterless self-nano emulsifying formula, ... after contact with saliva. We believe the spray will provide ...
(Date:6/27/2017)... , Jun 27, 2017   NuEyes (NuEyes Technologies ... funding to fuel its growth in helping the legally blind ... (Osterhout Design Group), the leading developer of augmented, virtual and ... sits. The undisclosed funding amount was provided by ... Arab Angel, with offices in Abu Dhabi ...
Breaking Medicine Technology: